Azithromycin Prophylaxis to Reduce Infection Risk Post C-Section
This NICHD study by Tita et al (NEJM, 2016) aimed to determine if prophylactic treatment with azithromycin before a non-elective C-section (laboring or ruptured membranes) reduces the rate of postoperative infection.
Randomized Controlled Trial (RCT)
2013 women with singleton pregnancies at ≥24 week’s gestation received antibiotic prophylaxis; 1,019 received 500mg IV azithromycin and 994 received a placebo. Primary outcomes included endometritis, wound infection, or other infection occurring within six weeks. Primary outcomes occurred in 62 (6.1%) women in the treatment group, and 119 (12%) in the placebo group (P<0.001). In addition, rates of endometritis were 3.8% in the treatment group and 6.1% in the placebo group (P=0.02), wound infection rates were 2.4% in the treatment group and 6.6% in the placebo group (P<0.001), and rate of serious maternal adverse events were 1.5% in the treatment group and 2.9% in the placebo group (P=0.03). There were no additional differences in composite newborn outcomes. The authors conclude that adjunctive azithromycin for cesarean delivery in women at increased risk for infection is safe, reduces infection rates does not increase risk to newborns.
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan